Global Breast Cancer Core Needle Biopsy Market Size & Outlook
Global breast cancer core needle biopsy market, 2018-2030 (US$M)
Related Markets
Global breast cancer core needle biopsy market highlights
- The global breast cancer core needle biopsy market generated a revenue of USD 822.0 million in 2023 and is expected to reach USD 1,151.4 million by 2030.
- The market is expected to grow at a CAGR (2024 - 2030) of 4.9% by 2030.
- In terms of segment, ultrasound-based breast biopsy accounted for a revenue of USD 283.8 million in 2023.
- Ultrasound-Based Breast Biopsy is the most lucrative technology segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2023.
- Country-wise, Denmark is expected to register the highest CAGR from 2024 to 2030.
Global data book summary
| Market revenue in 2023 | USD 822.0 million |
| Market revenue in 2030 | USD 1,151.4 million |
| Growth rate | 4.9% (CAGR from 2023 to 2030) |
| Largest segment | Ultrasound-based breast biopsy |
| Fastest growing segment | Ultrasound-Based Breast Biopsy |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | MRI-Based Breast Biopsy, Ultrasound-Based Breast Biopsy, Mammography-Based (Stereotactic) Breast Biopsy, CT-Based Breast Biopsy, Other Technologies |
Other key industry trends
- In terms of revenue, the North America accounted for 45.8% of the global breast cancer core needle biopsy market in 2023.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, Denmark is the fastest growing regional market and is projected to reach USD 7.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Breast Cancer Core Needle Biopsy Market Scope
Breast Cancer Core Needle Biopsy Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global breast cancer core needle biopsy market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to breast cancer core needle biopsy market will help companies and investors design strategic landscapes.
ultrasound-based breast biopsy was the largest segment with a revenue share of 34.53% in 2023. Horizon Databook has segmented the Global breast cancer core needle biopsy market based on mri-based breast biopsy, ultrasound-based breast biopsy, mammography-based (stereotactic) breast biopsy, ct-based breast biopsy, other technologies covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Breast Cancer Core Needle Biopsy Technology Outlook (Revenue, USD Million, 2018-2030)
- MRI-Based Breast Biopsy
- Ultrasound-Based Breast Biopsy
- Mammography-Based (Stereotactic) Breast Biopsy
- CT-Based Breast Biopsy
- Other Technologies
- Global Breast Cancer Core Needle Biopsy End use Outlook (Revenue, USD Million, 2018-2030)
- Hospitals & Diagnostic Laboratories
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
Reasons to subscribe to Global breast cancer core needle biopsy market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global breast cancer core needle biopsy market databook
-
Our clientele includes a mix of breast cancer core needle biopsy market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global breast cancer core needle biopsy market , including forecasts for subscribers. This global databook contains high-level insights into Global breast cancer core needle biopsy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global breast cancer core needle biopsy market statistics, by region, 2018-2030 (US$M)
Top 10 countries: Breast cancer core needle biopsy market size, 2023 (USD Million)
Top 10 countries: Breast cancer core needle biopsy market size, 2023 (USD Million)
Global breast cancer core needle biopsy market, by region, 2023 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
